Doctor profile · Federal record
Dr. Mezgebe Berhe, MD
Infectious Disease Physician (CMS: Infectious Disease) · Specialist · Dallas, TX
- NPI 1831155787
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3409 Worth St, 710
Dallas, TX 752462029
(214) 823-2533
fax (214) 824-8679
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- October 12, 2023
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Texas #M1510
- Medicaid
- TX #177738501
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831155787. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
111,163
Distinct HCPCS
10
Medicare allowed
$1,780,489
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0485 |
Injection, belatacept, 1 mg | 62,980 | 13 | $4 | |
J0897 |
Injection, denosumab, 1 mg | 35,100 | 361 | $23 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 8,380 | 11 | $48 | |
96372 |
Injection of drug or substance under skin or into muscle | 795 | 384 | $14 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 774 | 280 | $78 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 608 | 134 | $65 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 565 | 207 | $117 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 498 | 172 | $104 | |
J3489 |
Injection, zoledronic acid, 1 mg | 345 | 69 | $9 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 224 | 14 | $21 |
In context: peer comparison
Among 36 peers in Dallas Infectious Disease Physician, average services per provider: 1,026. This provider delivers 108× the peer median.Open Payments
Industry payments received
All-time total
$3,051
Transactions
87
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 38 | $1,221.42 | |
| Gilead Sciences, INC. | 14 | $956.24 | |
| Insmed, INC. | 9 | $230.93 | |
| Shionogi INC | 11 | $187.47 | |
| Merck Sharp & Dohme LLC | 4 | $161.57 | |
| Abbvie INC. | 4 | $109.35 | |
| Hospira, INC. | 3 | $52.94 | |
| Theratechnologies INC. | 1 | $52.23 | |
| Emd Serono, INC. | 2 | $48.75 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $29.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,216
Patients
189
Total drug cost
$1,725,859
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Daptomycin | Generic | 220 | 40 | $256,070 |
| Ertapenem (Ertapenem Sodium) | Brand | 146 | 33 | $83,506 |
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 140 | 16 | $554,084 |
| Meropenem | Generic | 107 | 20 | $34,464 |
| Vancomycin Hcl | Generic | 97 | 17 | $16,201 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 75 | 20 | $12,651 |
| Triumeq (Abacavir/Dolutegravir/Lamivudi) | Brand | 69 | 0 | $261,696 |
| Cefepime Hcl | Generic | 67 | 14 | $22,905 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 59 | 18 | $929 |
| Tivicay (Dolutegravir Sodium) | Brand | 51 | 0 | $149,529 |
Hospital affiliations
Frequently asked questions
What is Dr. Mezgebe Berhe's medical specialty?
Dr. Mezgebe Berhe practices Infectious Disease Physician in Dallas, TX.
Where does Dr. Mezgebe Berhe practice?
Dr. Mezgebe Berhe practices at 3409 Worth St, Dallas, TX 752462029. Office phone: 2148232533.
What is Dr. Mezgebe Berhe's NPI?
Dr. Mezgebe Berhe's National Provider Identifier (NPI) is 1831155787, issued by NPPES.
Does Dr. Mezgebe Berhe accept Medicare assignment?
Yes. Dr. Mezgebe Berhe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mezgebe Berhe commonly perform?
Top Medicare-reported procedures in 2023: Injection, belatacept, 1 mg (HCPCS J0485); Injection, denosumab, 1 mg (HCPCS J0897); Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS J1561). Source: CMS Medicare Physician & Other Practitioners file.